Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Research

| More

CEAT - Tight cost control supports performance - ICICI Securities

Posted On: 2020-07-29 22:14:26


CEAT's Q1FY21 operating performance was in line with consensus estimates as EBITDA margins came in at 9.3% (other expenses declined 494bps YoY). Admirably, CEAT hasn't yet squeezed employee costs (up 573 bps), possibly the high replacement (~58%) share of business is providing management growth/profitability comfort. On the balance sheet side, cash outflows have been restricted, gross debt remains stable QoQ at ~Rs20bn. Demand outlook for FY22 remains modest due to weakness in M&HCV demand (both in OEM, replacement segments), however, profitability is likely to remain healthy due to better mix and cost control. CEAT's capex cycle is largely behind us with FCF generation (Rs2.5bn) to start from FY22. Current valuations remain inexpensive as stock trades at ~7.2% FCF yield on FY22E basis. We maintain our BUY rating. Conference call on July 30, Thursday, at 16:00 hours IST. Number: +91 22 6280 1144.

- Key highlights of the quarter: Revenues declined ~37% YoY at ~Rs10.6bn from the loss of sales during first half of the quarter and lack of economic activity in M&HCV segment. Gross margins improved by 66bps YoY to 39.2bps. Employee costs remained sticky, up 573bps, even as other expenses fell 494bps as the company maintained tight cost control on discretionary spends and marketing costs. Debt stood at Rs19.98bn vis--vis Rs19.29bn in FY20 reflecting strong cashflow management. Company reported an exceptional loss of Rs15mn due to fire at the manufacturing facility. VRS expenses stood at Rs1.8mn for the quarter. CEAT report PAT loss of Rs146mn as interest costs rose by 228bps.

- Relatively better performance expected: CEAT has likely fared better vis--vis domestic peers, which we believe is attributable to: a) relatively high share of "2W+Farm" segment in revenues (~37%) which have witnessed best recovery across categories; b) new product innovations continues to drive market share gains in existing OEMs (e.g. Maruti Suzuki) ; and c) new customers additions (e.g. Kia, MG). In the CV segment, improvement in utilisation is a key monitorable as new TBR capacities ramp-up as industry could gain a respite due to curtailed imports.

- Maintain BUY: As we enter FY21, aftermarket growth is likely to taper down as a derivative impact of the sharp OEM slowdown in FY20. We tweak our earnings estimates (-1.8%/1.0% for FY21E/FY22E). We value CEAT on SoTP basis, upgrade our standalone multiple to 15x (earlier: 14x) FY22E EPS and reduce the ascribed unchanged value of SL/specialty business at Rs44 per share. We maintain BUY rating with a revised target price of Rs995 (earlier: Rs923).

Shares of CEAT LTD. was last trading in BSE at Rs.866.5 as compared to the previous close of Rs. 877.15. The total number of shares traded during the day was 15755 in over 954 trades.

The stock hit an intraday high of Rs. 889.05 and intraday low of 865.25. The net turnover during the day was Rs. 13844530.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

HeidelbergCement India - Play on better priced Central India; initiate with BUY - ICICI Securities

Healthcare - Diagnostics: Multiple tailwinds likely to emerge - ICICI Securities

Mazagon Dock Shipbuilders Ltd - IPO Review - ICICI Securities

Persistent Systems - 28th September 2020 - Angel Broking

Canara Bank - 28th September 2020 - Angel Broking

Subscribe to UTI Asset Management Company Limited - IPO Note - Angel Broking

Multiplex Sector - Mr. Jyoti Roy - DVP - Equity Strategist, Angel Broking Ltd

Sale of Sequent stake to Strides Pharma - Angel Broking

Subscribe to Mazagon Dock Shipbuilders Ltd - IPO Note - Angel Broking

JSW Energy - First big renewable step - ICICI Securities

V-MART Retail - Best play in value fashion segment; initiating with BUY - ICICI Securities

Gas sector - New winners and losers likely on policy changes in gas sector - ICICI Securities

Mazagon Dock Shipbuilders Limited - IPO Note - Geojit

UTI Asset Management Company Limited - IPO Note - Geojit

Preview on RBI Monetary Policy - Oct 2020 - Shanti Ekambaram

Rollover Report for September 2020 - October 2020: Angel Broking

Covid Recovery Pulse - Sep 25, 2020 - ICICI Securities

Quick Comment - Suven Pharmaceuticals - ICICI Securities

Derivatives Strategy - Sep 25, 2020 - Positional Option - ICICI Securities

Gladiator Stocks - Ramco Cement - ICICI Securities

IPO Review - UTI Asset Management Company - ICICI Securities

Stock of the Day - Zensar Technologies - Sep 25, 2020 - Angel Broking

Accenture Q4FY2020 Result - Angel Broking

Granules India receives ANDA approval - Angel Broking

Zydus Cadila receives US FDA approval - Angel Broking

Cipla - ANDA approval - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Mindspace REIT - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

UTI AMC - IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

Balkrishna Industries - Growth momentum continues - ICICI Securities

Rollover Analysis (September 25): Nifty starts October series with low OI amid high volatility

Derivatives View (September 25): Sell Bank Nifty in range of 20650-20750 - ICICI Securities

Rollover Analysis - Sept 20: Selling climax on expiry as markets crumble - YES Securities

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot

Bharat Forge - Expectation hurdle remains steep - ICICI Securities

Auto

Mutual Fund Review - September, 2020 - ICICI Securities

UTI AMC announces IPO date - Angel Broking

Asian Paints - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Britannia Industries - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Hexaware Technologies (Not Rated): Hexaware accepts 475/share as final delisting price - ICICI Securities

CAMS IPO - Day 2 Subscription - Angel Boking

Chemcon Speciality Chemicals - IPO subscribed 12.62 times on second day - Angel Broking







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019